Khiron Life Sciences Corp.
Rank 58
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.5333
USD
-1.35%
Market cap
$60,761,127
Total volume
$310,473
Shares outstanding
113,927,120
Rank 58
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$162,565
|
52.36% |
$0.5333
|
| KHRNF |
Total volume
$146,691
|
47.25% |
Stock price
$0.5700
|
Chart